Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldPlat Regulatory News (GDP)

Share Price Information for GoldPlat (GDP)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.125 (0.70%)
Bid:
17.50
Ask:
18.50
Spread: 1.00 (5.714%)
Market Cap: £30.74m
GDP Live PriceLast checked at - London Stock Exchange

Intraday GoldPlat Share Chart

Share buy-back programme

29 Mar 2022 07:00

RNS Number : 3074G
Goldplat plc
29 March 2022
 

 

 

 

Goldplat plc / Ticker: GDP / Index: AIM / Sector: Mining & Exploration 

 

 

29 March 2022

 

 

Goldplat plc('Goldplat', the 'Group' or 'the Company')

 

Share buy-back programme

 

 

Goldplat plc, the AIM listed gold producer, with international gold recovery operations located in South Africa and Ghana, is pleased to announce the launch of a share buy-back programme (the "Programme").

 

As previously announced, with the changes in strategy of the business to focus on the recovery operations, the intention of the Board is to distribute free cashflow generated in these operations back to shareholders, subsequent to regular reviews of capital allocations to optimise long-term returns for shareholders. The Board considered returning value to shareholders either through dividends or as a share buy-back. It is the Board's opinion that the Company's shares currently trade at significant discount to its intrinsic value per share, despite the strong operational and financial momentum of the business. The Board therefore believes that share buybacks are an appropriate means of returning value, whilst maximising sustainable long-term growth for shareholders, given the enhancement to net asset value, earnings and dividends per share that will result from reducing the number of shares in issue. The purpose of the Programme is therefore to reduce the issued ordinary share capital of the Company.

 

Accordingly, the Company today announces the commencement of the Programme, for the repurchase of its ordinary shares of one penny each ("Ordinary Shares") of up to a total value of £200,000. The Programme can commence from the date of this announcement and will expire at 30 June 2022, or when shares to the value of £200,000 have been bought back, if earlier. The Company has an arrangement with WH Ireland Limited ("WH Ireland") to run and manage the Programme and WH Ireland will have full discretion in relation to the Programme, within the parameters set out below, and are entitled to make independent trading and commercial decisions regarding the Programme.

 

Any purchase of Ordinary shares will be executed in accordance with the limits of the Company's general authority to

repurchase Ordinary shares granted by its shareholders at the Company's 2021 Annual General Meeting on 31 December 2021

· The maximum price at which Ordinary Shares may be purchased shall be 5 percent above the average of the middle market quotations for the Ordinary Shares as taken from the Daily Official List of the London Stock Exchange for the five business days preceding the date of purchase and the minimum price shall be £0.01, being the nominal value of the Ordinary Shares

· No more than 17,210,766 will be repurchased under the Programme.

 

It is intended that the Programme will be effected as far as possible in accordance with the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019). Given the level of liquidity in the Company's shares, Shareholders should be aware that a purchase of Ordinary Shares by the Company on any given trading day may represent a significant proportion of the daily trading volume in the Goldplat Ordinary Shares and could exceed 25 per cent of the average daily trading volume in the month preceding this announcement. The trading volume however will be limited to 50% of the average daily trading volume in the month preceding this announcement, which was circa 350,000 shares.

 

Under the terms of the agreement, WH Ireland will make purchases of the Shares under the buy-back programme independently of, and uninfluenced by, the Company. Purchases may continue during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information. 

 

All shares repurchased under the Programme will be cancelled.

 

The Board will keep the Programme under review to make sure it continues as an efficient and effective means of generating value for shareholders. While the Company has launched the Programme, there is no certainty on the volume of shares that may be acquired under the Programme and the pace of acquisitions.

 

The Company will make further announcements in due course following the completion of any buyback of shares.

 

For further information visit www.goldplat.com, follow on Twitter @GoldPlatGDP or contact:

 

Werner Klingenberg

 

Goldplat plc

(CEO)

 

Tel: +27 (0) 82 051 1071

Colin Aaronson / George Grainger / Samuel Littler

 

Grant Thornton UK LLP

(Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

Jessica Cave / Andrew de Andrade

 

WH Ireland Limited

(Broker)

 

Tel: +44 (0) 207 220 1666

 

Tim Thompson / Mark Edwards / Fergus Mellon

Flagstaff Strategic and Investor Communications

Tel: +44 (0) 207 129 1474

goldplat@flagstaffcomms.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFZGZFRRGGZZM
Date   Source Headline
6th Aug 20212:40 pmRNSExercise of Options and Total Voting Rights
5th Aug 20217:00 amRNSQuarterly Update - Update on 12 months 30 June 21
30th Jul 20217:00 amRNSTotal Voting Rights
23rd Jul 20212:57 pmRNSExercise of Options
20th Jul 20219:38 amRNSReplacement:Update on consideration for Kilimapesa
20th Jul 20217:08 amRNSUpdate on Consideration Receivable for Kilimapesa
20th Jul 20217:00 amRNSCorporate Transactions and Dividend Policy
19th Jul 20217:00 amRNSUpdate on consideration receivable for Kilimapesa
17th May 20217:00 amRNSUpdate on the nine months ended 31 March 2021
26th Apr 20217:00 amRNSCompletion of Sale of Kilimapesa Gold (Pty) Ltd
1st Apr 202110:00 amRNSUpdate on Sale of Kilimapesa
30th Mar 20217:00 amRNSResignation of Director
16th Mar 20211:18 pmRNSReplacement: Interim Results 31 Dec 20
12th Mar 20214:42 pmRNSInterim Results for the six months ended 31 Dec 21
11th Mar 20217:00 amRNSUpdate on sale of Kilimapesa
5th Mar 20217:00 amRNSInterim Results for the six months ended 31 Dec 20
2nd Mar 20217:00 amRNSUpdates on Group Structure and Interim Results
23rd Feb 20217:00 amRNSUpdate on sale of Kilimapesa
19th Feb 20218:24 amRNSUpdate on the Simplifying Group Structure
18th Feb 20217:38 amRNSUpdate on sale of Kilimapesa
15th Feb 20217:00 amRNSSimplifying Group Structure to Reduce Group Costs
8th Feb 20217:00 amRNSUpdate on six months ended 31 December 2020
22nd Jan 20217:00 amRNSLondon South East Investor Webinar
4th Jan 20218:45 amRNSUpdate on Sale of Kilimapesa
31st Dec 20201:23 pmRNSResult of AGM / Directorate Change
30th Dec 20207:15 amRNSNotice of Investor and Analyst Conference Call
9th Dec 20207:00 amRNSNotice of Investor and Analyst Conference Call
7th Dec 202011:46 amRNSPosting of Annual Report and Notice of AGM
30th Nov 20207:00 amRNSPreliminary Unaudited Results for YE 30 Jun 2020
11th Nov 202012:51 pmRNSUpdate on Preliminary Results & Sale of Kilimapesa
26th Oct 20207:17 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSQuarterly Update - Q1 Ended 30 Sept 2020
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 20207:00 amRNSUpdate on preliminary results & Sale of Kilimapesa
1st Oct 20207:00 amRNSUpdate - Preliminary Results & Sale of Kilimapesa
18th Sep 20207:05 amRNSUpdate on sale of Kilimapesa Pty Limited
3rd Sep 20207:12 amRNSUpdate on the sale of Kilimapesa Pty Limited
26th Aug 20207:32 amRNSHolding(s) in Company
4th Aug 20208:16 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSSigning of term sheet for sale of Kilimapesa Gold
28th Jul 20207:00 amRNSQuarterly Operational Update - Q4 30 June 2020
15th Jul 20204:16 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSExercise of Options
26th Jun 202012:57 pmRNSDirector/PDMR Shareholding
21st May 202010:03 amRNSHolding(s) in Company
14th May 202010:47 amRNSAppointment of Non-executive Director
28th Apr 20208:53 amRNSQuarterly Operational Update - Q3 31 March 2020
17th Apr 202011:49 amRNSHolding(s) in Company
17th Apr 20209:27 amRNSOperational Update in relation to COVID-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.